参考文献
1: Brunkhorst R, Vutukuri R, Pfeilschifter W. Fingolimod for the treatment of neurological diseases-state of play and future perspectives. Front Cell Neurosci. 2014 Sep 12;8:283. doi: 10.3389/fncel.2014.00283. eCollection 2014. Review. PubMed PMID: 25309325; PubMed Central PMCID: PMC4162362.
2: Harrison K. Fingolimod for multiple sclerosis: a review for the specialist nurse. Br J Nurs. 2014 Jun 12-25;23(11):582-9. Review. PubMed PMID: 24933548.
3: Thomas K, Ziemssen T. Management of fingolimod in clinical practice. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S60-4. doi: 10.1016/j.clineuro.2013.09.023. Review. PubMed PMID: 24321158.
4: Pilz G, Harrer A, Wipfler P, Oppermann K, Sellner J, Fazekas F, Trinka E, Kraus J. Tumefactive MS lesions under fingolimod: a case report and literature review. Neurology. 2013 Nov 5;81(19):1654-8. doi: 10.1212/01.wnl.0000435293.34351.11. Epub 2013 Oct 4. Review. Erratum in: Neurology. 2014 Apr 29;82(17):1569. PubMed PMID: 24097813.
5: Singer BA. Fingolimod for the treatment of relapsing multiple sclerosis. Expert Rev Neurother. 2013 Jun;13(6):589-602. doi: 10.1586/ern.13.52. Review. PubMed PMID: 23738997.
6: Willis MA, Cohen JA. Fingolimod therapy for multiple sclerosis. Semin Neurol. 2013 Feb;33(1):37-44. doi: 10.1055/s-0033-1343794. Epub 2013 May 25. Review. PubMed PMID: 23709211.
7: Groves A, Kihara Y, Chun J. Fingolimod: direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy. J Neurol Sci. 2013 May 15;328(1-2):9-18. doi: 10.1016/j.jns.2013.02.011. Epub 2013 Mar 19. Review. PubMed PMID: 23518370; PubMed Central PMCID: PMC3640626.
8: Széplaki G, Merkely B. [Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis]. Ideggyogy Sz. 2012 Nov 30;65(11-12):369-76. Review. Hungarian. PubMed PMID: 23289171.
9: Nikitin AV. [Molecular and cellular mechanisms of fingolimod action]. Antibiot Khimioter. 2013;58(11-12):38-42. Review. Russian. PubMed PMID: 24734428.
10: Liu J, Zhang C, Tao W, Liu M. Systematic review and meta-analysis of the efficacy of sphingosine-1-phosphate (S1P) receptor agonist FTY720 (fingolimod) in animal models of stroke. Int J Neurosci. 2013 Mar;123(3):163-9. doi: 10.3109/00207454.2012.749255. Epub 2012 Dec 21. Review. PubMed PMID: 23167788.
